Novo Nordisk
NYSE:NVO
$135.02
-$0.19
(-0.14%)
Quote as of 4:03 PM EST on 02/09/12
|
$135.02
-$0.19
(-0.14%)
|
|
| Today's Open | $133.15 |
|---|---|
| Previous Close | $135.21 |
| Daily Range | $133.15 - $135.22 |
| 52-Week Range | $94.58 - $135.68 |
| Market Cap | $78.31B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | $1.36 (1.3%) |
| Ex-Dividend Date Dividend Pay Date |
03/22/12 04/02/12 |
| Volume | 239,060 |
| Average Daily Volume | 324,237 |
| Current FY EPS | $5.85 |
NVO Information
| Description |
|---|
| Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Novo Nordisk Posts Solid 4Q - Analyst Blog
Novo Nordisk May Perform Stock Split - Chief Financial Officer
Novo Nordisk Raises Guidance As Earnings Beat Views
Amylin Shares Rise on Diabetes Drug Approval, Challenges Loom
Third Time Lucky for Amylin's Bydureon - Analyst Blog
UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays
2nd UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays
